Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
- Publicado em
- 2 abr 2024
- Citações
- 14
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials
Syed Muhammad Muneeb Akhtar, Abraish Ali, Muhammad Sohaib Khan, Vareesha Khan, Areeba Fareed, Syed Zia Saleem, Munazza Mumtaz, Muhammad Nadeem Ahsan, Sadia Iqbal, Muhammad Sohaib Asghar
Descritores MeSH
- Postmenopause
- Hot Flashes
- Heterocyclic Compounds, 2-Ring
- Humans
- Middle Aged
- Quality of Life
- Cycloheptanes
- Thiadiazoles
- Vasomotor System
- Randomized Controlled Trials as Topic
Veja também
Estudos relacionados
- Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
- Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause
- Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
- Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis